Oncolytics Biotech, Inc. Common Stock (ONCY)
search
Earnings reactions
How ONCY moved on each past earnings report.
Up
Down
Earnings Impact
Oncolytics Biotech, Inc. Common Stock (ONCY) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Oncolytics Biotech, Inc. Common Stock (ONCY) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 15 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
15
Funds holding
$609975
Total value held
Buying
15 added · 0 reduced
Goldman Sachs Group Inc
$161386
NEW BUY
Invesco Ltd.
$96125
NEW BUY
Franklin Resources Inc
$75842
NEW BUY
Royal Bank Of Canada
$55000
NEW BUY
Fifth Third Bancorp
$43245
NEW BUY
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260818 | open_in_new SEC.gov |
| 10-Q | 20260812 | open_in_new SEC.gov |
| 8-K | 20260724 | open_in_new SEC.gov |
| 8-K | 20260720 | open_in_new SEC.gov |
| 8-K | 20260713 | open_in_new SEC.gov |
| 8-K | 20260708 | open_in_new SEC.gov |
| 8-K | 20260616 | open_in_new SEC.gov |
| 3 | 20260603 | open_in_new SEC.gov |
| 3 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |